International Stem Cell CORP SEC filings ISCO
International Stem Cell CORP has 825 filings in SEC EDGAR's recent list, going back to Apr 4, 2006. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | May 13, 2020 | Dec 31, 2019 |
| NT 10-Q | Filing | Aug 14, 2019 | Jun 30, 2019 |
| NT 10-K | Filing | Apr 1, 2019 | Dec 31, 2018 |
| NT 10-Q | Filing | May 15, 2018 | Mar 31, 2018 |
| NT 10-K | Filing | Apr 2, 2018 | Dec 31, 2017 |
| RW | Filing | Mar 8, 2018 | — |
| EFFECT | Filing | Jun 14, 2017 | — |
| EFFECT | Filing | May 9, 2016 | — |
| EFFECT | Filing | Nov 2, 2015 | — |
| EFFECT | Filing | Feb 6, 2015 | — |
| EFFECT | Filing | Nov 25, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2014 | — |
| D | Filing | Oct 23, 2014 | — |
| CORRESP | Letter to the SEC | Oct 23, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2014 | — |
| EFFECT | Filing | Apr 10, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2014 | — |
| CORRESP | Letter to the SEC | Mar 19, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2014 | — |
| EFFECT | Filing | Jan 13, 2014 | — |
| EFFECT | Filing | Jul 18, 2013 | — |
| CORRESP | Letter to the SEC | Jul 15, 2013 | — |
| CORRESP | Letter to the SEC | Jul 15, 2013 | — |
| CORRESP | Letter to the SEC | Jul 11, 2013 | — |
| CORRESP | Letter to the SEC | Jul 10, 2013 | — |
| CORRESP | Letter to the SEC | Jul 9, 2013 | — |
| 424A | Filing | Jul 2, 2013 | — |
| CORRESP | Letter to the SEC | Jun 19, 2013 | — |
| UPLOAD | Letter from the SEC | May 20, 2013 | — |
| CORRESP | Letter to the SEC | Dec 7, 2012 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2012 | — |
| NT 10-Q | Notification of late filing | May 10, 2012 | Mar 31, 2012 |
| EFFECT | Filing | May 7, 2012 | — |
| D | Filing | Mar 20, 2012 | — |
| NT 10-K | Notification of late filing | Mar 16, 2012 | Dec 31, 2011 |
| NT 10-Q | Form 12b-25 | May 16, 2011 | Mar 31, 2011 |
| EFFECT | Filing | Apr 15, 2011 | — |
| EFFECT | Filing | Dec 30, 2010 | — |
| CORRESP | Letter to the SEC | Dec 30, 2010 | — |
| CORRESP | Letter to the SEC | Dec 30, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2010 | — |
| EFFECT | Filing | May 4, 2010 | — |
| CORRESP | Letter to the SEC | Apr 28, 2010 | — |
| CORRESP | Letter to the SEC | Apr 19, 2010 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2010 | — |
| EFFECT | Filing | Sep 30, 2009 | — |
| CORRESP | Letter to the SEC | Sep 28, 2009 | — |
| CORRESP | Letter to the SEC | Sep 22, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2009 | — |
| CORRESP | Letter to the SEC | Sep 3, 2009 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2009 | — |
| 10KSB | Form 10-ksb | Mar 18, 2008 | Dec 31, 2007 |
| 10QSB | International stem cell corporation | Nov 14, 2007 | Sep 30, 2007 |
| 10QSB | Form 10-qsb | Aug 14, 2007 | Jun 30, 2007 |
| EFFECT | Filing | Jul 12, 2007 | — |
| CORRESP | Letter to the SEC | Jul 11, 2007 | — |
| SB-2/A | Amendment no. 5 to the form sb-2 | Jul 9, 2007 | — |
| 10KSB/A | Form 10ksb/a | Jul 9, 2007 | Dec 31, 2006 |
| 10QSB/A | Form 10qsb/a | Jul 9, 2007 | Mar 31, 2007 |
| SB-2/A | Amendment no. 4 to form sb-2 | Jul 2, 2007 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2007 | — |
| 10QSB/A | Form 10qsb/a | Jun 27, 2007 | Mar 31, 2007 |
| 10KSB/A | Form 10ksb/a | Jun 27, 2007 | Dec 31, 2006 |
| SB-2/A | Amendment no.3 to form sb-2 | Jun 20, 2007 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2007 | — |
| SB-2/A | Amendment no. 2 to form sb-2 | May 31, 2007 | — |
| UPLOAD | Letter from the SEC | May 18, 2007 | — |
| 10QSB | Form 10-qsb | May 15, 2007 | Mar 31, 2007 |
| CORRESP | Letter to the SEC | Apr 24, 2007 | — |
| SB-2/A | Amendment no.1 to form sb-2 | Apr 24, 2007 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2007 | — |
| SB-2 | Form sb-2 | Apr 11, 2007 | — |
| 10KSB | Form 10ksb | Apr 9, 2007 | Dec 31, 2006 |
| NT 10-K | Filing | Apr 3, 2007 | Dec 31, 2006 |
| REGDEX/A | Auto-generated paper document | Jan 30, 2007 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2007 | — |
| SC 14F1 | Schedule 14f-1 | Dec 29, 2006 | — |
| 10QSB | Filing | Oct 30, 2006 | Sep 30, 2006 |
| 10QSB | Filing | Aug 1, 2006 | Jun 30, 2006 |
| 10QSB | Filing | Aug 1, 2006 | Mar 31, 2006 |
| 10SB12G/A | Filing | May 24, 2006 | — |
| 10SB12G/A | Filing | May 15, 2006 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2006 | — |
| 10SB12G | Filing | Apr 4, 2006 | — |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ISCO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1355790
- Former names
- BTHC III INC. (until Jan 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.